Entries by CAPTIS

Charles River, Takeda announce scientific collaboration to identify and develop preclinical candidates

Together, Charles River and Takeda will launch multiple integrated programs across Takeda’s four core therapeutic areas—oncology, gastroenterology, neuroscience, and rare disease—with the ultimate goal of delivering preclinical candidates The post Charles River, Takeda announce scientific collaboration to identify and develop preclinical candidates appeared first on Pharmaceutical Business review.

Bayer to commercialise Daré’s monthly contraceptive Ovaprene in US

Ovaprene is Daré’s investigational hormone-free monthly vaginal contraceptive, which is under clinical development to prevent pregnancy. Under the exclusive licence agreement, Bayer will commercialise Ovaprene after it is The post Bayer to commercialise Daré’s monthly contraceptive Ovaprene in US appeared first on Pharmaceutical Business review.